Radically improving healthspan with a novel multifactorial approach to osteoarthritis
Executive Team
David Miles: CEO
Commercial executive, previously Head of Inflammatory diseases, Europe at Pfizer. Linkedin
Alan Reynolds: CSO
Clinical Scientist, previously European Clinical Science Director for Inflammation at Wyeth/ Pfizer. Linkedin
Dr. Nicholas Larkins: CRO, Co-Founder
Former director and head of research at NAF (Natural Animal Feeds). Clinician and scientist with research interests focusing on the microbiome and manipulation of inflammatory pathways. Linkedin
Michael Martin: CFO
Investor and adviser to startup companies in bio-science and education. Former investment banker in London, New York, Paris. Linkedin
Wendy Richings Barrow: Regulatory
Healthcare Regulatory Consultant. 35 years at Lederle Laboratories/Pfizer in Regulatory Affairs Licensing & Acquisitions. Linkedin
David Sharples: Chair, Co-Founder
Serial entrepreneur, experienced in recruiting and supervising strong management teams, fund-raising, commercial deals and company trade sales. Linkedin